Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Hansoh Pharmaand MSDannounced that they have entered into an exclusive global license agreement for HS an investigational preclinical oral small molecule GLP receptor agonist
Clarity Pharmaceuticalsa clinicalstage radiopharmaceutical company with a mission to develop nextgeneration products that improve treatment outcomes for children and adults with cancer is pleased to announce the expansion of its pipeline
Shanghai Juncell Therapeutics Co Ltd a clinicalstage biotech focused on innovative ILindependent TumorInfiltrating Lymphocyte TIL therapies announced the grand opening of its stateoftheart TIL manufacturing facility located
Scinai Immunotherapeutics Ltda biopharmaceutical company focused on developing inflammation and immunology II biological products and providing CDMO services through its Scinai Bioservices business unit
Everest Medicinesa biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced that the National Medical Products Administration
BioThera Solutions a commercialstage biopharmaceutical company developing innovative therapies and biosimilars today announced an expansion of their partnership with SteinCares today with the addition
Nona Biosciences a global biotechnology company providing a total solution from Idea to IND I to ITM today announced a research collaboration and license agreement to discover nextgeneration Tcell engagers TCEs with Candid Therapeutics
Novo Nordisk announced plans to invest billion Danish kroner to establish a completely new production facility in Odense Denmark The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new pro...
Gilead Sciences Inc today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA adopted a positive opinion recommending seladelpar
NEC Bio Therapeutics today presents week promising interim results from an ongoing Phase basket clinical trial of an orally administered cancer vaccine NECVAXNEO used in combination with checkpoint inhibitors CPI for treating patients with solid tum...
